A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer

Phase I ◽

Phase I Trial ◽

Autologous Blood ◽

Metastatic Breast ◽

High Dose ◽

Stem Cell Support ◽

Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support

10.1038/sj.bmt.1701907 ◽

1999 ◽

Vol 24 (4) ◽

pp. 377-384 ◽

Cited By ~ 19

Author(s):

M Bewick ◽

T Chadderton ◽

M Conlon ◽

R Lafrenie ◽

D Morris ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Autologous Blood ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

Her 2 ◽

Stem Cell Dose and Tumorbiologic Parameters as Prognostic Markers for Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy with Autologous Blood Stem Cell Support

Stem Cells ◽

10.1634/stemcells.20-1-32 ◽

2002 ◽

Vol 20 (1) ◽

pp. 32-40 ◽

Cited By ~ 7

Author(s):

Manfred Hensel ◽

Andreas Schneeweiss ◽

Hans-Peter Sinn ◽

Gerlinde Egerer ◽

Martin Kornacker ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Prognostic Markers ◽

Autologous Blood ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

Expression of C-Erb B-2/Her-2 in Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy and Autologous Blood Stem Cell Support

Molecular Biology of Hematopoiesis 6 ◽

10.1007/978-1-4615-4797-6_12 ◽

1999 ◽

pp. 91-102

Author(s):

M. Bewick ◽

T. Chadderton ◽

M. Conlon ◽

R. Lafrenie ◽

Stefan Glück

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Autologous Blood ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

Her 2 ◽

HER-2 expression is a prognostic factor in patients with metastatic breast cancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support

10.1038/sj.bmt.1703005 ◽

2001 ◽

Vol 27 (8) ◽

pp. 847-853 ◽

Cited By ~ 18

Author(s):

M Bewick ◽

M Conlon ◽

S Gerard ◽

H Lee ◽

AM Parissenti ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Prognostic Factor ◽

Autologous Blood ◽

Metastatic Breast ◽

High Dose ◽

Stem Cell Support ◽

Her 2 ◽

HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support

10.1038/sj.bmt.1704619 ◽

2004 ◽

Vol 34 (5) ◽

pp. 413-417 ◽

Cited By ~ 7

Author(s):

V Guarneri ◽

C Bengala ◽

C Orlandini ◽

A Gennari ◽

S Donati ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Her2 Overexpression ◽

Breast Cancer Patients ◽

Stem Cell Support ◽

Single-Agent Paclitaxel in Patients With Metastatic Breast Cancer Receiving High-Dose Chemotherapy With Peripheral Blood Stem Cell Support

American Journal of Clinical Oncology ◽

10.1097/00000421-199904000-00011 ◽

1999 ◽

Vol 22 (2) ◽

pp. 162-167

Author(s):

L. S. Schwartzberg ◽

C. H. Weaver ◽

R. Birch ◽

R. Giudice ◽

E. Sobong ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Peripheral Blood Stem Cell ◽

Single Agent ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

High-Dose Taxol, Cyclophosphamide, and Cisplatin with Stem Cell Support in the Treatment of Metastatic Breast Cancer

The Breast Journal ◽

10.1046/j.1524-4741.1998.430165.x ◽

1998 ◽

Vol 4 (3) ◽

pp. 165-170

Author(s):

Svetislava J. Vukelja ◽

W. Jeffery Baker ◽

Miriam Y.J. Atkins ◽

Nicole Lee ◽

Joseph J. Stephenson

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast ◽

High Dose ◽

Stem Cell Support ◽

High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer

10.1038/sj.bmt.1700870 ◽

1997 ◽

Vol 20 (3) ◽

pp. 199-203 ◽

Cited By ~ 9

Author(s):

P Viens ◽

G Gravis ◽

D Genre ◽

F Bertucci ◽

D Cowen ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast ◽

High Dose ◽

Sequential Chemotherapy ◽

Stem Cell Support ◽

PET-FDG Imaging in Metastatic Breast Cancer Treated with High Dose Chemotherapy and Stem Cell Support.

10.21236/ada319987 ◽

1996 ◽

Author(s):

Abass Alavi

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study

European Journal of Cancer ◽

10.1016/s0959-8049(01)81543-4 ◽

2001 ◽

Vol 37 ◽

pp. S285 ◽

Cited By ~ 14

Author(s):

S. Gluck ◽

M. Crump ◽

D. Stewart ◽

M. Levine ◽

K. Pritchard ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trials ◽

Stem Cell ◽

Peripheral Blood Stem Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽